{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVYTF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVYTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVYTF\",,,,,undefined,":{"symbol":"NVYTF","market":"US","secType":"STK","nameCN":"Novacyt Clamart","latestPrice":0.538,"timestamp":1745956800000,"preClose":0.538,"halted":0,"volume":0,"delay":15,"floatShares":70458323,"shares":70605812,"eps":-0.51025,"marketStatus":"Post-Mkt","change":0,"latestTime":"04-29 16:00:00 EDT Delay","open":0.538,"high":0.538,"low":0.538,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.51025,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745971200000},"marketStatusCode":4,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.538,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVYTF\",,,,,undefined,":{"symbol":"NVYTF","floatShares":70458323,"roa":"-27.98%","roe":"-42.04%","lyrEps":-0.51025,"shares":70605812,"dividePrice":0,"high":0.538,"amplitude":0,"preClose":0.538,"low":0.538,"week52Low":0.5374,"pbRate":"0.40","psRate":"1.53","week52High":1.25,"institutionHeld":0,"latestPrice":0.538,"eps":-0.51025,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.51025,"open":0.538,"prevYearClose":0.627,"prevWeekClose":0.538,"prevMonthClose":0.641,"prevQuarterClose":0.641,"fiveDayClose":0.538,"twentyDayClose":0.641,"sixtyDayClose":0.627},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVYTF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2470771279","title":"Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2470771279","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470771279?lang=en_us&edition=fundamental","pubTime":"2024-09-27 17:00","pubTimestamp":1727427659,"startTime":"0","endTime":"0","summary":"Revenue: Increased year-on-year by GBP 7 million to over GBP 10 million, driven by the inclusion of Yourgene sales post-acquisition.Gross Profit: Delivered GBP 26.5 million, inflated by the reversal of a GBP 19.8 million product warranty provision. Underlying gross margin was GBP 6.7 million or 65%.EBITDA: Broadly flat year-on-year at a loss of GBP 5.6 million.Net Cash Inflow: Over GBP 7 million from the successful resolution of the DHSC dispute.OpEx: Increased to over GBP 32 million due to a GBP 20 million bad debt provision. Underlying OpEx costs were GBP 12.1 million compared to GBP 7 million in the prior period.Exceptional Costs: Totaling just over GBP 8 million, primarily related to the DHSC settlement.Loss After Tax: GBP 17.7 million attributable to owners in H1.Geographic Revenue: Europe delivered sales of over GBP 5.5 million, with the UK market contributing over GBP 2.3 million and France GBP 1.3 million. Asia Pacific region accounted for over 25% of group revenue.Cost Savings","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wXEf8SiTka04dTTmDYMjcw--~B/aD0xMDI7dz0yMjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3eedda5d30f868e0a6ddd59ac5729fec","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wXEf8SiTka04dTTmDYMjcw--~B/aD0xMDI7dz0yMjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3eedda5d30f868e0a6ddd59ac5729fec"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novacyt-sa-nvytf-q2-2024-090059981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVYTF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVYTF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-30","symbol":"NVYTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-09-29","symbol":"NVYTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1664424000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVYTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVYTF\",market:\"US\",delay:false,,,undefined,":{}}}